Therapeutic combinations and compositions for the treatment of inflammatory bowel diseaseDijkstra, G., Faber, K. N., Harmsen, H. J. M., Steinert, R., Sybesma, W. & Topchyan, A., 13-Aug-2020, Patent No. WO2020161088, 4-Feb-2020, Priority date 4-Feb-2019
Research output: Patent
The present invention relates to pharmaceutical combinations of at least one thiopurine and/or at least a pharmaceutically acceptable salt and/or at least one prodrug thereof and riboflavin to treat patients suffering from inflammatory bowel disease (IBD) or other inflammatory conditions. This invention also relates to additive and/or combinations of at least one thiopurine and riboflavin. This invention is also related to a method for the treatment or prophylaxis of IBD or other inflammatory conditions, which method comprises administering a therapeutically effective amount of thiopurine and riboflavin.
|Publication status||Published - 13-Aug-2020|